RPG Life Sciences Limited

NSE:RPGLIFE.NS

2369.2 (INR) • At close September 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 1,689.21,430.91,727.11,722.11,654.21,269.91,5371,535.81,477.81,184.91,3061,347.91,289.31,0081,155.81,126.51,081.3870.21,076971.3916.5822.5943.7984.9940.4625.6909.7905798.9834.6956.6895.1761.7712.7645.4763.8852.3689.3731.7684.1674.4670582575.1595.6527.4568605.5641.8617.7480.9570.6547.2
Cost of Revenue 600.2487.2561.1541.7930.4780.1481.7447.4871.8394.9424.7453.7435.4446362.3344.3349.5391.7382.3309.7292.7305.2319326.1327.3232.4292.7327.7247.6274.9333.4309.3237251.1216.7283.6307224.4227.8224.4237.8211.6193.7214.1227.5184193.6189200.9209.4181188.6185.4
Gross Profit 1,089943.71,1661,180.4723.8489.81,055.31,088.4606790881.3894.2853.9562793.5782.2731.8478.5693.7661.6623.8517.3624.7658.8613.1393.2617577.3551.3559.7623.2585.8524.7461.6428.7480.2545.3464.9503.9459.7436.6458.4388.3361368.1343.4374.4416.5440.9408.3299.9382361.8
Gross Profit Ratio 0.6450.660.6750.6850.4380.3860.6870.7090.410.6670.6750.6630.6620.5580.6870.6940.6770.550.6450.6810.6810.6290.6620.6690.6520.6290.6780.6380.690.6710.6510.6540.6890.6480.6640.6290.640.6740.6890.6720.6470.6840.6670.6280.6180.6510.6590.6880.6870.6610.6240.6690.661
Reseach & Development Expenses 0000093.600089.300089.700088.800093.300092.3000129.500000000000102.500075.500073.7000
General & Administrative Expenses 00000114.5000344.6000143.8000235000195.7000214.500026200000000000193.600051.600047.1000
Selling & Marketing Expenses 00000213000168.1000146.600010100074.800073.400093.90000000000017.7000121.9000120.5000
SG&A 031600386327.5339.4379.6325.7512.7306.3317.7304.7290.4296.9266.5266.3336243.7244.1240270.5241.7249.3231.2287.9239.4238.6222.2355.9231.3217.2204.2269.9197.1186.3181.9136.9202.2177.7179.3211.3127.9190.1157448.7219.1174147.2425.8139.100
Other Expenses 785.70729774.20-93.6378.3378.2018.45.112.3613.812.66.17.14.1-5.11.20.44.5422.75171.51.6-0.10.20.63.93.25.10.60.91.21.11.81.80.1451.7426.6405.8412.5352.8428.7352.9366.8425.4396.9373.7353.2343.8359.5316.5
Operating Expenses 785.7316729774.2386327.5717.7757.8325.7669.8628.3635.6613.8454.5591.8564.1541.9378.4522.6512.4496.9422.7517536.3498.8357.6534.8536.4519510.7539500.6511.3445.9414.6437.4444.4440451.7426.6405.8412.5352.8428.7352.9366.8425.4396.9373.7353.2343.8359.5316.5
Operating Income 303.3627.7437406.2337.8162.3337.6330.6280.3129.3258.1270.9252.397.3201.7218.1189.9100.1171.1149.2126.994.6107.7122.5114.335.682.240.932.34984.285.213.415.714.142.8100.924.952.233.130.845.935.5-67.715.2-23.4-5119.667.255.1-43.922.545.3
Operating Income Ratio 0.180.4390.2530.2360.2040.1280.220.2150.190.1090.1980.2010.1960.0970.1750.1940.1760.1150.1590.1540.1380.1150.1140.1240.1220.0570.090.0450.040.0590.0880.0950.0180.0220.0220.0560.1180.0360.0710.0480.0460.0690.061-0.1180.026-0.044-0.090.0320.1050.089-0.0910.0390.083
Total Other Income Expenses Net 51721.331.9-255.322.215.117.817.317.4-0.54.411.511.11.84.55.42.8-10.6-0.4-1.91.4-63.2-3.2-2.1-5.7-14.4-9.9-9.9-6.5-5.1-4.2-10.2-8.7-8.7-13.873.8-2.2-2.4-5.1-3-6.61.1-8.8-7-4.27.4-3.4-2.6634.9-19.8-19.6-17.4-16.8
Income Before Tax 354.31,349468.9150.9360177.4355.4347.9297.7138.1257.4270.1251.2109.3206.2223.5192.789.5170.7147.3128.331.4104.1120.4108.621.272.53125.843.980754.765.5116.698.722.546.725.621.44726.7-74.711-6.6-54.417693.735.3-63.55.128.5
Income Before Tax Ratio 0.210.9430.2710.0880.2180.140.2310.2270.2010.1170.1970.20.1950.1080.1780.1980.1780.1030.1590.1520.140.0380.110.1220.1150.0340.080.0340.0320.0530.0840.0840.0060.0080.0090.1530.1160.0330.0640.0370.0320.070.046-0.130.018-0.013-0.0960.0281.0810.057-0.1320.0090.052
Income Tax Expense 91.4175.5119.6108.992.44590.889.376.734.666.370.469.134.159.96656.920.34235.837.71.62522.725.15.819.7-9.47.531.425.411.90.48.11.114.11.80.100001.4-0.8-0.6-1.5-24.2-5.4146.8-38.7-2.620.6
Net Income 262.91,173.5349.342267.6132.4264.6258.6221103.5191.1199.7182.175.2146.3157.5135.869.2128.7111.590.629.879.197.783.515.452.821.618.312.554.663.14.3-2.15.5102.598.722.546.725.621.44725.3-73.911.6-5.1-30.222.4546.974-60.93.127.9
Net Income Ratio 0.1560.820.2020.0240.1620.1040.1720.1680.150.0870.1460.1480.1410.0750.1270.140.1260.080.120.1150.0990.0360.0840.0990.0890.0250.0580.0240.0230.0150.0570.070.006-0.0030.0090.1340.1160.0330.0640.0370.0320.070.043-0.1280.019-0.01-0.0530.0370.8520.12-0.1270.0050.051
EPS 15.970.9621.122.5416.188.011615.6413.366.2611.5512.0811.014.558.859.528.214.187.786.745.481.84.785.915.050.933.191.311.110.763.33.820.26-0.130.676.224.851.362.821.551.292.841.53-4.470.7-0.31-1.831.3633.074.47-3.680.181.69
EPS Diluted 15.970.9621.122.5416.188.011615.6413.366.2611.5512.0811.014.558.859.528.214.187.786.745.481.84.785.915.050.933.191.311.110.763.33.820.26-0.120.676.224.851.362.821.551.292.841.53-4.470.7-0.31-1.831.3633.074.47-3.680.181.69
EBITDA 407254.775524.7205.7414.4207.2398.2391.2340.5177.5297.2309.6290.6147.7247.1265.1233.6129.6214.2191.617375.6149.3165.6155.169.712179.673.389125.3121.649.151.447.8142.3106.650.176.959.356.384.666.1-37.737.83.9-23.945.992.680.4-18.246.569
EBITDA Ratio 0.2410.1780.3040.1190.2510.1630.2590.2550.230.150.2280.230.2250.1470.2140.2350.2160.1490.1990.1970.1890.0920.1580.1680.1650.1110.1330.0880.0920.1070.1310.1360.0640.0720.0740.1860.1250.0730.1050.0870.0830.1260.114-0.0660.0630.007-0.0420.0760.1440.13-0.0380.0810.126